Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4atac small nuclear 12, pseudogene (abbreviation RNU4ATAC12P) is a human pseudogene annotated as a non-coding RNA that does not encode a protein and is not recognized as a functional molecular target for therapeutic intervention[1]. RNU4ATAC12P is a pseudogene representing a non-functional copy of the U4atac small nuclear RNA gene. Pseudogenes, historically considered “junk DNA,” do not encode functional proteins but can sometimes generate non-coding RNA transcripts. In general, this pseudogene is not linked to any known biological function, disease process, or therapeutic use[1]. The functional counterpart of this family (RNU4ATAC, not RNU4ATAC12P) encodes a component of the minor spliceosome, and rare variants in that functional gene (RNU4ATAC) are associated with developmental syndromes such as Taybi-Linder/MOPD1, Roifman, and Lowry-Wood syndromes[4]. There is no evidence that RNU4ATAC12P itself is involved in disease, is expressed, or acts as a biomarker or target[1]. - While some pseudogenes have been implicated in regulatory functions via competing endogenous RNA interactions or generation of small interfering RNAs[5][6][7], there is no published evidence to support significant functionality, disease linkage, or therapeutic relevance for RNU4ATAC12P specifically. - For structured databases and drug discovery pipelines, RNU4ATAC12P should not be treated as a receptor, enzyme, transporter, or any other drug target class. - If there was an intent to refer to the functional RNU4ATAC gene, note that this is distinct from RNU4ATAC12P and is a non-coding gene affecting the minor spliceosome and relevant to rare inherited disorders when mutated[4]. Key Points: - RNU4ATAC12P is a pseudogene—not a protein, receptor, or therapeutic target[1]. - It has no established biological function, disease association, or pharmacological relevance[1]. - Any information conflating this pseudogene with its protein-coding or functional non-coding relatives should be corrected. If you require information on the true therapeutic target "U4atac small nuclear RNA" (RNU4ATAC), please clarify and the relevant details can be provided for that gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 12, pseudogene (RNU4ATAC12P).